Neurobiology of addiction. Toward the development of new therapies

Annals of the New York Academy of Sciences

Volumn 909, Issue , 2000, Pages 170-185

  Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG; DRUG RECEPTOR; GLUTAMIC ACID; NEUROTRANSMITTER; OPIATE PEPTIDE; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; BRAIN DYSFUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG USE; DYSPHORIA; FOREBRAIN; HUMAN; IRRITABILITY; MESENCEPHALON; NEGATIVE SYNDROME; NEUROBIOLOGY; NEUROPHARMACOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; RAT; REINFORCEMENT; RELAPSE; SYMPTOM; THEORY; WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0033913561     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06682.x     Document Type: Conference Paper

References (111)

1. 1. AMERICAN PSYCHIATRIC ASSOCIATION. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. American Psychiatric Press. Washington, DC.
2. 2. WORLD HEALTH ORGANIZATION. 1992. International Statistical Classification of Diseases and Related Problems, 10th Revision. World Health Organization. Geneva.
3. 3. WIKLER, A. 1973. Dynamics of drug dependence: implications of a conditioning theory for research and treatment. Arch. Gen. Psychiatry 28: 611-616.
4. 4. GILL, K., Z. AMIT & B.K. KOE. 1988. Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats. Alcohol 5: 349-354.
5. 5. SOLOMON, R.L. 1977. The opponent-process theory of acquired motivation: the affective dynamics of addiction. In Psychopathology: Experimental Models. J.D. Maser & M.E.P. Seligman, Eds. :124-145. W.H. Freeman. San Francisco, CA.
6. 6. KOOB, G.F. & M. LE MOAL. 1997. Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58.
7. 7. RUSSELL, M.A.H. 1976. What is dependence? In Drugs and Drug Dependence. G. Edwards, M.A.H. Russell, D. Hawks & M. MacCafferty, Eds. :182-187. Lexington Books. Lexington, MA.
8. 8. JOHANSON, C.E. & R.L. BALSTER. 1978. A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull. Narc. 30: 43-54.
9. 9. SCHUSTER, C.R. & T. THOMPSON. 1969. Self-administration and behavioral dependence on drugs. Annu. Rev. Pharmacol. Toxicol. 9: 483-502.
10. 10. SCHUSTER, C.R. & C.E. JOHANSON. 1988. Relationship between the discriminative stimulus properties and subjective effects of drugs. In Transduction Mechanisms of Drug Stimuli. F. C. Colpaert & R. L. Balster, Eds. :161-175. Springer-Verlag. Berlin.
11. 11. COLLINS, R.J., J.R. WEEKS, M.M. COOPER, P.I. GOOD & R.R. RUSSELL. 1984. Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology 82: 6-13.
12. 12. CARR, G.D., H.C. FIBIGER & A.G. PHILLIPS. 1989. Conditioned place preference as a measure of drug reward. In The Neuropharmacological Basis of Reward. J.M. Liebman & S.J. Cooper, Eds. :264-319. Oxford University Press. New York.
13. 13. KORNETSKY, C. & R.U. ESPOSITO. 1979. Euphorigenic drugs: effects on the reward pathways of the brain. Federation Proc. 38: 2473-2476.
14. 14. COLLINS, R.J., J.R. WEEKS, M.M. COOPER, P.I. GOOD & R.R. RUSSELL. 1984. Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology 82: 6-13.
15. 15. DAVIS, W.M. & S.G. SMITH. 1975. Effect of haloperidol on (+)-amphetamine self-administration. J. Pharm. Pharmacol. 27: 540-542.
16. 16. DEWIT, H. & R.A. WISE. 1977. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozidc, but not with the noradrenergic blockers phentolaine and phenoxybenzamine. Can. J. Psychol. 31: 195-203.
17. 17. WOOLVERTON, W.L. & K.M. JOHNSON. 1992. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13: 193-200.
18. 18. MALIN, D.H., J.R. LAKE, V.A. CARTER, J.S. CUNNINGHAM & O.B. WILSON. 1993. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112: 339-342.
19. 19. MALIN, D.H., J.R. LAKE, V.A. CARTER, J.S. CUNNINGHAM, K.M. HEBERT, D.L. CONRAD & D.L. WILSON. 1994. The nicotine antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 115: 180-184.
20. 20. ROBERTS, D.C. S., G.F. KOOB, P. KLONOFF & H.C. FIBIGER. 1980. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12: 781-787.
21. 21. LYNESS, W.H., N.M. FRIEDLE & K.E. MOORE. 1979. Destruction of dopaminergic nerve terminals in nucleus accumbens: effect of d-amphetamine self-administration. Pharmacol. Biochem. Behav. 11: 553-556.
22. 22. DANI, J.A. & S. HEINEMANN. 1996. Molecular and cellular aspects of nicotine abuse. Neuron 16: 905-908.
23. 23. KOOB, G.F., F.J. VACCARINO, M. AMALRIC & F.E. BLOOM. 1987. Positive reinforcement properties of drugs: search for neural substrates. In Brain Reward Systems and Abuse. J. Engel & L. Oreland, Eds. :35-50. Raven Press. New York.
24. 24. WEISS, F., A. MARKOU, M.T. LORANG & G.F. KOOB. 1992. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited access self-administration. Brain Res. 593: 314-318.
25. 25. HURD, Y.L., F. WEISS, G.F. KOOB, N.E. AND & U. UNGERSTEDT. 1989. Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. Brain Res. 489: 199-203.
26. 26. WEISS, F., Y.L. HURD, U. UNGERSTEDT, A. MARKOU, P.M. PLOTSKY & G.F. KOOB. 1992. Neurochemical correlates of cocaine and ethanol self-administration. In The Neurobiology of Drug and Alcohol Addiction. P.W. Kalivas & H. Samson, Eds. Ann. N.Y. Acad. Sci. 654: 220-241. New York Academy of Sciences. New York.
27. 27. WEISS, F., M.P. PAULUS, M.T. LORANG & G.F. KOOB. 1992. Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and chronic administration. J. Neurosci. 12: 4372-4380.
28. 28. KOOB, G.F., H.T. LE & I. CREESE. 1987. The D-1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79: 315-320.
29. 29. WOOLVERTON, W.L. & R.M. VIRUS. 1989. The effects of a D1 and D2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol. Biochem. Behav. 32: 691-697.
30. 30. BERGMAN, J., J.B. KAMIEN & R.D. SPEALMAN. 1990. Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists. Behav. Pharmacol. 1: 355-363.
31. 31. CAINE, S.B. & G.F. KOOB. 1993. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260: 1814-1816.
32. 32. CAINE, S.B., S.C. HEINRICHS, V.L. COFFIN & G.F. KOOB. 1995. Effects of the dopamine D1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692: 47-56.
33. 33. EPPING-JORDAN, M.P., A. MARKOU & G.F. KOOB. 1998. The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat. Brain Res. 784: 105-115.
34. 34. GOLDBERG, S.R., J.H. WOODS & C.R. SCHUSTER. 1971. Nalorphine-induced changes in morphine self-administration in rhesus monkeys. J. Pharmacol. Exp. Ther. 176: 464-471.
35. 35. WEEKS, J.R. & R.J. COLLINS. 1976. Changes in morphine self-administration in rats induced by prostaglandin E1 and naloxone. Prostaglandins 12: 11-19.
36. 36. ETTENBERG, A., H.O. PETTIT, F.E. BLOOM & G.F. KOOB. 1982. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78: 204-209.
37. 37. KOOB, G.F., H.O. PETTIT, A. ETTENBERG & F.E. BLOOM. 1984. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J. Pharmacol. Exp. Ther. 229: 481-486.
38. 38. VACCARINO, F.J., H.O. PETTIT, F.E. BLOOM & G.F. KOOB. 1985. Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat. Pharmacol. Biochem. Behav. 23: 495-498.
39. 39. NEGUS, S.S., S.J. HENRIKSEN, A. MATTOX, G.W. PASTERNAK, P.S. PORTOGHESE, A.E. TAKEMORI, M.B. WEINGER & G.F. KOOB. 1993. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats, J. Pharmacol. Exp. Ther. 265: 1245-1252.
40. 40. MATTHES, H.W., R. MALDONADO, F. SIMONIN, O. VALVERDE, S. SLOWE, I. KITCHEN, K. BEFORT, A. DIERICH, M. LE MEUR, P. DOLLE, E. TZAVARA, J. HANOUNE, B.P. ROQUES & B.L. KIEFFER. 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819-823.
41. 41. BRITT, M.D. & R.A. WISE. 1983. Ventral tegmental site of opiate reward: antagonism by a hydrophilic opiate receptor blocker. Brain Res. 258: 105-108.
42. 42. VACCARINO, F.J., F.E. BLOOM & G.F. KOOB. 1985. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 86: 37-42.
43. 43. GOEDERS, N.E., J.D. LANE & J.E. SMITH. 1984. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20: 451-455.
44. 44. DI CHIARA, G. & R.A. NORTH. 1992. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13: 185-193.
45. 45. SHIPPENBERG, T.S., A. HERZ, R. SPANAGEL, R. BALS-KUBIK & C. STEIN. 1992. Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. In The Neurobiology of Drug and Alcohol Addiction. P. W. Kalivas & H. H. Samson, Eds. Ann. N.Y. Acad. Sci. 654: 347-356. New York Academy of Sciences. New York.
46. 46. HEMBY, S.E., T.J. MARTIN, C. CO, S.I. DWORKIN & J.E. SMITH. 1995. The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis. J. Pharmacol. Exp. Ther. 273: 591-598.
47. 47. DI CHIARA, G. & A. IMPERATO. 1988. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244: 1067-1080.
48. 48. DI CHIARA, G. & A. IMPERATO. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278.
49. 49. PONTIERI, F.E., G. TANDA & G. DI CHIARA. 1995. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA 92: 12304-12308.
50. 50. PETTIT, H.O., A. ETTENBERG, F.E. BLOOM & G.F. KOOB. 1984. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84: 167-173.
51. 51. STINUS, L., D. NADAUD, J.M. DEMINIERE, J. JAUREGUI, T.T. HAND & M. LE MOAL. 1989. Chronic flupentixol treatment potentiates the reinforcing properties of systemic heroin administration. Biol. Psychiatry 26: 363-371.
52. 52. ENGEL, J.A., C. ENERBACK, C. FAHLKE, P. HULTHE, E. HARD, K. JOHANNESSEN, L. SVENSSON & B. SODERPALM. 1992. Serotonergic and dopaminergic involvement in ethanol intake. In Novel Pharmacological Interventions for Alcoholism. C.A. Naranjo & E.M. Sellers, Eds. :68-82. Springer. New York.
53. 53. TABAKOFF, B. & P.L. HOFFMAN. 1992. Alcohol: neurobiology. In Substance Abuse. A Comprehensive Textbook. J. H. Lowinson, P. Ruiz & R. B. Millman, Eds. :152-185. Williams and Wilkins. Baltimore, MD.
54. 54. RICHARDS, G., P. SCHOCH & W. HAEFELY. 1991. Benzodiazepine receptors: new vistas. Seminars Neurosci. 3: 191-203.
55. 55. KOOB, G.F. & K.T. BRITTON. 1996. Neurobiological substrates for the anti-anxiety effects of ethanol. In The Pharmacology of Alcohol and Alcohol Dependence. H. Begleiter & B. Kissin, Eds. :477-506. Oxford University Press. New York.
56. 56. FRYE, G.D. & G.R. BREESE. 1982. GABAergic modulation of ethanol-induced motor impairment. J. Pharmacol. Exp. Ther. 223: 750-756.
57. 57. LILJEQUIST, S. & J. ENGEL. 1982. Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes. Psychopharmacology 78: 71-75.
58. 58. HYYTIA, P. & G.F. KOOB. 1995. GABA-A receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur. J. Pharmacol. 283: 151-159.
59. 59. PFEFFER, A.O. & H.H. SAMSON. 1988. Haloperidol and apomorphine effects on ethanol reinforcement in free feeding rats. Pharmacol. Biochem. Behav. 29: 343-350.
60. 60. SAMSON, H.H., C.W. HODGE, G.A. TOLLIVER & M. HARAGUCHI. 1993. Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbens. Brain Res. Bull. 30: 133-141.
61. 61. RASSNICK, S., L. STINUS & G.F. KOOB. 1993. The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res. 623: 16-24.
62. 62. MYERS, R.D. & S.D. QUARFORDT. 1991. Alcohol drinking attenuated by sertraline in rats with 6-OHDA or 5,7-DHT lesions of N. accumbens: a caloric response. Pharmacol. Biochem. Behav. 40: 923-928.
63. 63. SELLERS, E.M., G.A. HIGGINS & M.B. SOBELL. 1992. 5-HT and alcohol abuse. Trends Pharmacol. Sci. 13: 69-75.
64. 64. HUBBELL, C.L., S.H. MARGLIN, S.J. SPITALNIC, M.L. ABELSON, K.D. WILD & L.D. REID. 1991. Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage. Alcohol 8: 355-367.
65. 65. HYYTIA, P. 1993. Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol. Biochem. Behav. 45: 697-701.
66. 66. HEYSER, C.J., A.J. ROBERTS, G. SCHULTEIS & G.F. KOOB, 1999. Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Alcohol. Clin. Exp. Res. 23: 1468-1476.
67. 67. HOFFMAN, P.L., C. RABE, F. MOSES & B. TABAKOFF. 1989. N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J. Neurochem. 52: 1937-1940.
68. 68. LOVINGER, D.M., G. WHITE & F.F. WEIGHT. 1989. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243: 1721-1724.
69. 69. GRANT, K.A. & G. COLOMBO. 1993. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-asparate antagonists. J. Pharmacol. Exp. Ther. 264: 1241-1247.
70. 70. ALHEID, G F. & L. HEIMER. 1988. New perspectives in basal forebrain organization of special relevance for neuropsychiatrie disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 27: 1-39.
71. 71. KOOB, G.F. 1999. The role of the striatopallidal and extended amygdala systems in drug addiction. In Advancing from the Ventral Striatum to the Extended Amygdala: Implications for Neuropsychiatry and Drug Abuse. J. F. McGinty, Ed. Ann. N.Y. Acad. Sci. 877: 445-460. New York Academy of Sciences. New York.
72. 72. JOHNSTON, J.B. 1923. Further contributions to the study of the evolution of the forebrain. J. Comp. Neurol. 35: 337-481.
73. 73. HEIMER, L. & G. ALHEID. 1991. Piercing together the puzzle of basal forebrain anatomy. In The Basal Forebrain: Anatomy to Function. T. C. Napier, Ed. Adv. Exp. Med. Biol. 295: 1-42. Plenum Press. New York.
74. 74. HEIMER, L., D.S. ZAHM, L. CHURCHILL, P.W. KALIVAS & C. WOHLTMANN. 1991. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41: 89-125.
75. 75. TANDA, G., F.E. PONTIERI & G. DI CHIARA. 1997. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mul opioid receptor mechanism. Science 276: 2048-2050.
76. 76. PONTIERI, F.E., G. TANDA, F. ORZI & G. DI CHIARA. 1996. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382: 255-257.
77. 77. GAWIN, F.H. & H.D. KLEBER. 1986. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch. Gen. Psychiatry 43: 107-113.
78. 78. MARKOU, A. & G.F. KOOB. 1991. Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology 4: 17-26.
79. 79. SCHULTEIS, G., A. MARKOU, L.H. GOLD, L. STINUS & G.F. KOOB. 1994. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J. Pharmacol. Exp. Ther. 271: 1391-1398.
80. 80. LEITH, N.J. & R.J. BARRETT. 1976. Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychopharmacologia 46: 19-25.
81. 81. PARSONS, L.H., G.F. KOOB & F. WEISS. 1995. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J. Pharmacol. Exp. Ther. 274: 1182-1191.
82. 82. MARKOU, A. & G.F. KOOB. 1992. Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations. Physiol. Behav. 51: 111-119.
83. 83. LEGAULT, M. & R.A. WISE. 1994. Effects of withdrawal from nicotine on intracranial self-stimulation. Soc. Neurosci. Abstr. 20: 1032.
84. 84. KOOB, G.F. & F.E. BLOOM. 1988. Cellular and molecular mechanisms of drug dependence. Science 242: 715-723.
85. 85. WEISS, F., A. MARKOU, M.T. LORANG & G.F. KOOB. 1992. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited access self-administration. Brain Res. 593: 314-318.
86. 86. STINUS, L., M. LE MOAL & G.F. KOOB. 1990. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37: 767-773.
87. 87. ROBERTS, A.J., M. COLE & G.F. KOOB. 1996. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol. Clin. Exp. Res. 20: 1289-1298.
88. 88. WEISS, F., L.H. PARSONS, G. SCHULTEIS, P. HYYTIA, M.T. LORANG, F.E. BLOOM & G.F. KOOB. 1996. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J. Neurosci. 16: 3474-3485.
89. 89. FITZGERALD, L.W. & E.J. NESTLER. 1995. Molecular and cellular adaptations in signal transduction pathways following ethanol exposure. Clin. Neurosci. 3: 165-173.
90. 90. COLLINS, A.C., R.V. BHAT, J.R. PAULY & M.J. MARKS. 1990. Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. In The Biology of Nicotine Dependence. G. Bock & J. Marsh, Eds. Ciba Foundation Symp. 152: 87-105. John Wiley. New York.
91. 91. KREEK, M.J. 1987. Multiple drug abuse patterns and medical consequences. In Psychopharmacology: The Third Generation of Progress. H.Y. Meltzer, Ed. :1597-1604. Raven Press. New York.
92. 92. KREEK, M.J., J. RAGUNATH, S. PLEVY, D. HAMER, B. SCHNEIDER & N. HARTMAN. 1984. ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans. Neuropeptides 5: 277-278.
93. 93. KOOB, G.F., S C. HEINRICHS, F. MENZAGHI, E. MERLO-PICH & K.T. BRITTON. 1994. Corticotropin-releasing factor, stress and behavior. Seminars Neurosci. 6: 221-229.
94. 94. HEINRICHS, S.C., F. MENZAGHI, G. SCHULTEIS, G.F. KOOB & L. STINUS. 1995. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav. Pharmacol. 6: 74-80.
95. 95. RODRIGUEZ DE FONSECA, F., M.R.A. CARRERA, M. NAVARRO, G.F. KOOB & F. WEISS. 1997. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276: 2050-2054.
96. 96. RICHTER, R.M. & F. WEISS. 1999. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32: 254-261.
97. 97. RASSNICK, S., S.C. HEINRICHS, K.T. BRITTON & G.F. KOOB. 1993. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605: 25-32.
98. 98. SARNYAI, Z., E. BIRO, J. GARDI, M. VECSERNYES, J. JULESZ & G. TELEGDY. 1995. Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats. Brain Res. 675: 89-97.
99. 99. MERLO-PICH, E., M. LORANG, M. YEGANEH, F. RODRIGUEZ DE FONSECA, J. RABER, G.F. KOOB & F. WEISS. 1995. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15: 5439-5447.
100. 100. INFORMAL EXPERT GROUP MEETING ON THE CRAVING MECHANISM. 1992. Report no. V.92-54439T. United Nations International Drug Control Programme and World Health Organization. Geneva.
101. 101. MARKOU, A., F. WEISS, L.H. GOLD, S.B. CAINE, G. SCHULTEIS & G.F. KOOB. 1993. Animal models of drug craving. Psychopharmacology 112: 163-182.
102. 102. SOLOMON, R.L. 1980. The opponent process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am. J. Psychol. 35: 691-712.
103. 103. O'BRIEN, C.P. 1975. Experimental analysis of conditioning factors in human narcotic addiction. Pharmacol. Rev. 27: 533-543.
104. 104. EVERITT, B.J., K.A. MORRIS, A. O'BRIEN & T.W. ROBBINS. 1991. The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes. Neuroscience 42: 1-18.
105. 105. SCHULTEIS, G., S. AHMED, A.C. MORSE, G.F. KOOB & B.J. EVERITT. 2000. Lesions of the basolateral amygdala abolish conditioned opiate withdrawal. Nature. In press.
106. 106. SPANAGEL, R. & F. WEISS. 1999. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22: 521-527.
107. 107. PILLA, M., S. PERACHON, F. SAUTEL, F. GARRIDO, A. MANN, C.G. WERMUTH, J.C. SCHWARTZ, B.J. EVERITT & P. SOKOLOFF. 1999. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D-3 receptor agonist. Nature 400: 371-375.
108. 108. ROBERTS, A.J., C.J. HEYSER, M. COLE, P. GRIFFIN & G.F. KOOB. 2000. Excessive ethanol drinking following a history of dependence: animal model or allostasis. Neuropsychopharmacology 22: 581-594.
109. 109. AHMED, S.H. & G.F. KOOB. 1998. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282: 298-300.
110. 110. AHMED, S.H. & G.F. KOOB. 1999. Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology 146: 303-312.
111. 111. SCHULTEIS, G., A. MARKOU, M. COLE & G.F. KOOB. 1995. Decreased brain reward produced by ethanol withdrawal. Proc. Natl. Acad. Sci. USA 92: 5880-5884.